Randomized, Multi-Center, Double-Blinded, Placebo Controlled Safety and Early Efficacy Trial of Cryopreserved Cord Blood Derived T-Regulatory Cell Infusions (CK0802) in the Treatment of COVID-19 Induced ARDS. (RESOLVE Trial)

Background. COVID19 associated moderate to severe acute respiratory distress syndrome (ARDS) is associated with high rates of morbidity and mortality. Immune dysfunction and hyper-inflammatory responses result in a vicious cycle of tissue inflammation and end organ damage. Based on the suggestion of...

Descripción completa

Detalles Bibliográficos
Autores principales: Gladstone, Douglas E, Howard, Christopher, Lyu, Mi-Ae, Mock, Jason, Adams, Darryl, Gibbs, Kevin, Li, Li, Huang, Meixian, Zeng, Ke, D'Alessio, Franco, Herlihy, James, Trevino, Sergio, Hari, Parameswaran, Sadeghi, Tara, Parmar, Simrit, Slutsky, Arthur, Mukherjee, Siddhartha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
704.Cellular Immunotherapies: Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701590/
http://dx.doi.org/10.1182/blood-2021-153616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701590/
http://dx.doi.org/10.1182/blood-2021-153616

Ejemplares similares